Ottawa Hospital Research Institute
🇨🇦Canada
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT03759782
- Locations
- 🇨🇦
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
🇨🇦Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
RA Effect on Cell Surface Molecules in Vivo
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Ottawa Hospital Research Institute
- Registration Number
- NCT03753867
Recovernow: Tablet-Based Speech Therapy For Post-Stroke Aphasia
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 33
- Registration Number
- NCT03755063
- Locations
- 🇨🇦
University Health Network / University of Toronto, Toronto, Ontario, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT03746925
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 150
- Registration Number
- NCT03713255
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Efficacy of Lymphovenous Bypass in the Treatment of Extremity Lymphedema
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Ottawa Hospital Research Institute
- Registration Number
- NCT03683095
Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT03677557
- Locations
- 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada
Nasal Packing Following Endoscopic Endonasal Pituitary Resection
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03677713
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03665311
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ont, Canada
Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 211
- Registration Number
- NCT03664687
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
© Copyright 2024. All Rights Reserved by MedPath